ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Income Statement 2013–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenue | 113.3M | 14.7M | 622,000 | 240,000 | 934,000 | 605,000 | 2.2M | 47,000 | 45,000 | 44,000 | 236,000 | 641,000 | 600,000 |
| Gross Profit | 112.5M | 14.7M | 622,000 | 240,000 | — | — | — | — | — | — | — | — | — |
| Profitability | |||||||||||||
| Operating Income | -256.0M | -344.2M | -362.3M | -351.3M | -330.3M | -220.9M | -156.3M | -98.4M | -99.1M | -124.5M | -238.9M | -5.6M | — |
| EBITDA | -240.5M | -326.6M | -343.7M | -333.0M | -316.0M | -208.1M | -142.2M | -88.8M | -93.6M | -120.9M | -237.4M | -5.5M | — |
| Net Income | -351.4M | -413.6M | -583.2M | -416.6M | -346.8M | -221.9M | -157.8M | -96.2M | -96.4M | -120.8M | -236.9M | -6.2M | -2.0M |
| Per Share Data | |||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 920M | 700M | 509M | 400M | 389M | 377M | 366M | 79M | 79M | 82M | 81M | — | — |
ImmunityBio, Inc. Income Statement — FAQ
ImmunityBio, Inc. (IBRX) income statement over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IBRX's income statement history?
The chart and table above show ImmunityBio, Inc.'s income statement by year and by quarter, including the growth rate.